Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Oakes

Showing results (11-20 of 119) with videos related to

Pageof 12
Sort By:
Controlled Clinical Trials|December 31, 2002
Design and analysis of two-period studies of potentially disease-modifying treatmentsMichael P McDermott, W J Hall, David Oakes, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|February 24, 2009
IL-1beta augments TNF-alpha-mediated inflammatory responses from lung epithelial cellsSara Saperstein, Linlin Chen, David Oakes, et al.
Parkinsonism & Related Disorders|December 6, 2008
Levels of the light subunit of neurofilament triplet protein in cerebrospinal fluid in Huntington's diseaseRadu Constantinescu, Megan Romer, David Oakes, et al.
Journal of Parkinson'S Disease|June 13, 2022
Longitudinal Cohort Study of Verbatim-Reported Postural Instability Symptoms as Outcomes for Online Parkinson's Disease TrialsIra Shoulson, Lakshmi Arbatti, Abhishek Hosamath, et al.
Gender Medicine|November 9, 2010
Gender differences in mortality in patients with severe sepsis or septic shockAnthony P Pietropaoli, Laurent G Glance, David Oakes, et al.
Annals of Clinical and Translational Neurology|June 19, 2019
Phenotype-genotype discrepancies in the prospective Huntington at-risk observational studyIra Shoulson, Shirley Eberly, David Oakes, et al.
Journal of Parkinson'S Disease|July 27, 2014
Impact of disclosure of individual imaging results in a multi-center Parkinson clinical trialDanna Jennings, Shirley Eberly, David Oakes, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 4, 2018
Selected health and lifestyle factors, cytosine-adenine-guanine status, and phenoconversion in Huntington's diseaseCaroline Tanner, Karen Marder, Shirley Eberly, et al.
Journal of Parkinson'S Disease|July 12, 2021
Predictive Value of Verbatim Parkinson's Disease Patient-Reported Symptoms of Postural Instability and FallingMonica Javidnia, Lakshmi Arbatti, Abhishek Hosamath, et al.
Annals of Clinical and Translational Neurology|January 18, 2021
Isradipine plasma pharmacokinetics and exposure-response in early Parkinson's diseaseCharles S Venuto, Luoying Yang, Monica Javidnia, et al.
Pageof 12

Showing results (11-20 of 119) with videos related to

Sort By:
Pageof 12
Controlled Clinical Trials|December 31, 2002
Design and analysis of two-period studies of potentially disease-modifying treatmentsMichael P McDermott, W J Hall, David Oakes, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|February 24, 2009
IL-1beta augments TNF-alpha-mediated inflammatory responses from lung epithelial cellsSara Saperstein, Linlin Chen, David Oakes, et al.
Parkinsonism & Related Disorders|December 6, 2008
Levels of the light subunit of neurofilament triplet protein in cerebrospinal fluid in Huntington's diseaseRadu Constantinescu, Megan Romer, David Oakes, et al.
Journal of Parkinson'S Disease|June 13, 2022
Longitudinal Cohort Study of Verbatim-Reported Postural Instability Symptoms as Outcomes for Online Parkinson's Disease TrialsIra Shoulson, Lakshmi Arbatti, Abhishek Hosamath, et al.
Gender Medicine|November 9, 2010
Gender differences in mortality in patients with severe sepsis or septic shockAnthony P Pietropaoli, Laurent G Glance, David Oakes, et al.
Annals of Clinical and Translational Neurology|June 19, 2019
Phenotype-genotype discrepancies in the prospective Huntington at-risk observational studyIra Shoulson, Shirley Eberly, David Oakes, et al.
Journal of Parkinson'S Disease|July 27, 2014
Impact of disclosure of individual imaging results in a multi-center Parkinson clinical trialDanna Jennings, Shirley Eberly, David Oakes, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 4, 2018
Selected health and lifestyle factors, cytosine-adenine-guanine status, and phenoconversion in Huntington's diseaseCaroline Tanner, Karen Marder, Shirley Eberly, et al.
Journal of Parkinson'S Disease|July 12, 2021
Predictive Value of Verbatim Parkinson's Disease Patient-Reported Symptoms of Postural Instability and FallingMonica Javidnia, Lakshmi Arbatti, Abhishek Hosamath, et al.
Annals of Clinical and Translational Neurology|January 18, 2021
Isradipine plasma pharmacokinetics and exposure-response in early Parkinson's diseaseCharles S Venuto, Luoying Yang, Monica Javidnia, et al.
Pageof 12